Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 2,214

Document Document Title
WO/2003/027050A2
A process for preparing substituted pentacene compounds comprises the step of cyclizing substituted bis(benzyl)phthalic acids using an acid composition comprising trifluoromethanesulfonic acid, the substituted bis(benzyl)phthalic acids b...  
WO/2003/016407A1
The invention relates to new thioxanthone compounds having utility as fluorescent dyes and processes for their manufacture.  
WO/2003/013420A2
A non-toxic biologically active compound is provided having the following general formula (I), wherein n is an integer from 1 to 14, preferably from 2 to 4, and R is an organic moiety, preferably a group different from but structurally s...  
WO2002030860A9
The present invention relates to novel ketone compounds, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders c...  
WO/2003/009807A2
Cytoprotective compounds, many of which are phenolic derivatives characterized by a substituded phenol having certain conjugated bonds, are useful in the treatment of certain ischemic or inflammatory conditions, including but not limited...  
WO/2003/007933A1
Provided are napthoquinone-type compounds which can be used to modulate the aggregation of protein (e.g. tau) associated with neurodegenerative disease (e.g. Alzheimer's disease). Structure-function characteristics for oxidised and reduc...  
WO2002029014A3
Provided is a stem-cell differentiation and induction promoter, which comprises as an effective ingredient a cyclohexenone long-chain alcoholic derivative represented by the formula (1):[wherein, R<1>, R<2> and R<3> each independently re...  
WO/2002/090304A1
By maintaining reduced coenzyme Q, which has not been employed in practice so far because of being liable to undergo oxidation and hydrophobic, stable against oxidation, a composition of a practically usable solution of reduced coenzyme ...  
WO2001042243A3
Disclosed are compounds which inhibit or modulate the activity of protein kinases and pharmaceutical compositions containing such compounds. The disclosed compound contain two or more ligand moieties covalently linked together by one or ...  
WO2002050007A3
The present invention relates to stilbene and quinone compounds related to combretastatin A-4 and their use as anticancer compounds and prodrugs. The compounds include those with an alkyl group on the double bond of cis or trans-stilbene...  
WO/2002/076939A2
Compounds having quinone and quinone analogs useful for pharmaceutical preparations have now been found which inhibit cysteine proteases, in particular, caspases and 3C-cysteine proteases. The cysteine protease inhibitors of the present ...  
WO/2002/076916A1
A method of scavenging oxygen in an atmosphere or liquid comprising the steps of: (i) treating an anthraquinone compound according to the formula: (I) wherein X1-X4 and R1-R4 are as defined in the claims, with predetermined conditions so...  
WO/2002/074800A1
This invention relates to the gene cluster for angucycline biosynthesis, derived from Streptomyces, and use of the genes therein to obtain antibiotics for drug screening.  
WO2001045681A3
Substituted naphthalenediones in accord with structural diagram (I): compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection. In compound...  
WO2002030860A3
The present invention relates to novel ketone compounds, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders c...  
WO/2002/050007A2
The present invention relates to stilbene and quinone compounds related to combretastatin A-4 and their use as anticancer compounds and prodrugs. The compounds include those with an alkyl group on the double bond of cis or trans-stilbene...  
WO2002012158A3
The invention relates to a method for catalytically producing organic substances by partial oxidation which is carried out in the gaseous phase in the presence of molecular oxygen at temperatures in the range of from 200 to 500 DEG C in ...  
WO/2002/030860A2
The present invention relates to novel ketone compounds, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders c...  
WO/2002/029014A2
Provided is a stem-cell differentiation and induction promoter, which comprises as an effective ingredient a cyclohexenone long-chain alcoholic derivative represented by the formula (1):[wherein, R?1¿, R?2¿ and R?3¿ each independently...  
WO/2002/028808A1
This invention provides analogs of triptycene which are useful as anticancer drugs, as well as for other uses. The potency of these compounds is in a similar magnitude as daunomycin, a currently used anticancer drug. Each compound of the...  
WO2001078162A3
OLED materials are provided that have the general formula: R<1>-(Ar)n-R<2> wherein the subscript n is an integer of from 5 to 15; the superscript i is an integer of from 1 to n and denotes the position downstream from R<1>; each Ar is a ...  
WO/2002/014530A1
The present invention provides a convergent method for the synthesis of ubiquinones and ubiquinone analogues. Also provided are precursors of ubiquinones and their analogues that are useful in the methods of the invention.  
WO/2002/011563A1
A food supplement having prophylactic and-cancer effects, wherein the supplement comprises 20 to 99.99 % by weight of a product of biosynthesis by the productive microorganism Penicillium oxalicum var. Armeniaca CCM 8242, obtained by fer...  
WO/2002/012158A2
The invention relates to a method for catalytically producing organic substances by partial oxidation which is carried out in the gaseous phase in the presence of molecular oxygen at temperatures in the range of from 200 to 500 °C in at...  
WO/2002/012218A1
The present invention is based in part on the surprising discovery that Tanshinones from Salvia miltiorrhiza act as allosteric high-potency N-methyl-D-aspartate receptor antagonists. Pharmacological blockade of excessive activation of N-...  
WO/2002/006261A1
The invention relates to the use of at least one component of formula (I) wherein R?1¿, R?2¿, R?3¿ and R?4¿ independently represent H or C¿1?-C¿6? alkyl. The invention also relates to the use of a compound of formula (I) for medica...  
WO2001046125A3
Substituted phenantheren-9, 10-diones in accord with structural diagram (I), compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection. In ...  
WO2000039064A9
New compounds of formula (I) are described, wherein n is > 1; X is O or NR4; L is a n-valent linking group defined in claim 1 and R1 is H, halogen, C1-C25-alkyl, C3-C25-alkenyl, unsubstituted or by C1-C4-alkyl substituted C5-C8-cycloalky...  
WO/2001/078162A2
OLED materials are provided that have the general formula: R?1¿-(Ar?i¿)¿n?-R?2¿ wherein the subscript n is an integer of from 5 to 15; the superscript i is an integer of from 1 to n and denotes the position downstream from R?1¿; eac...  
WO/2001/077052A1
Improved oxidation methods are provided wherein a reaction mixture comprising a substrate to be oxidized (e.g., phenols, alkenes) and an oxidation catalyst (typically dispersed in an organic solvent system) is supplemented with a compres...  
WO/2001/068579A1
The invention relates to a method for producing 1,1' binaphthalenylidene-4,4'-diones of general formula (I), wherein R?1¿ represents C¿1-6? alkyl, C¿1-6? alkoxy, phenyl, substituted phenyl, benzyl or benzyloxy; R?2¿, R?3¿, R?4¿, an...  
WO/2001/054730A1
The invention relates to a method for producing a coenzyme Q10 / $g(g)-cyclodextrin complex. Said method is characterized in that a mixture of $g(g)-cyclodextrin and coenzyme Q10 is treated by homogenisation and inputting energy.  
WO2001000554A3
Naphthoquinone derivatives of Formula (1): wherein, R represents an OH group, methyl ether, ethyl ether or a similar ether; R1 represents a methyl, ethyl or similar aliphatic hydrocarbon derivative; R2 and R3 each independently represent...  
WO/2001/046125A2
Substituted phenantheren-9, 10-diones in accord with structural diagram (I), compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection. In ...  
WO/2001/045681A2
Substituted naphthalenediones in accord with structural diagram (I): compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection. In compound...  
WO/2001/042243A2
Disclosed are compounds which inhibit or modulate the activity of protein kinases and pharmaceutical compositions containing such compounds. The disclosed compound contain two or more ligand moieties covalently linked together by one or ...  
WO/2001/026482A1
A composition, preferably used to reduce methane formation in a ruminant, wherein the composition is a combination of a polycyclic quinone compound and an ionophore compound.  
WO2000066528A3
Novel quinones are provided, as well as compositions comprising these novel quinones. Methods of using the novel quinones in treatment of various indications including cancer are also provided.  
WO/2001/000554A2
Naphthoquinone derivatives of Formula (1): wherein, R represents an OH group, methyl ether, ethyl ether or a similar ether; R1 represents a methyl, ethyl or similar aliphatic hydrocarbon derivative; R2 and R3 each independently represent...  
WO/2000/066528A2
Novel quinones are provided, as well as compositions comprising these novel quinones. Methods of using the novel quinones in treatment of various indications including cancer are also provided.  
WO/2000/053655A1
The invention relates to conjugated polymers which contain triptycene units. According to the invention, the polymers are homopolymers made up of a repeating unit which contains a triptycenyl radical and copolymers made up of two or more...  
WO/2000/039064A1
New compounds of formula (I) are described, wherein n is > 1; X is O or NR¿4?; L is a n-valent linking group defined in claim 1 and R¿1? is H, halogen, C¿1?-C¿25?-alkyl, C¿3?-C¿25?-alkenyl, unsubstituted or by C¿1?-C¿4?-alkyl sub...  
WO2000008495A3
The present invention provides a compound selected from the group consisting of (I), (II), and (III), wherein R<1> and R<4> are the same or different and are each H, C1-C3 alkyl, phosphate, or C1-C3 alkyl carboxylate; R<2> and R<3> are t...  
WO/2000/023377A1
The invention concerns a novel method for preparing MEL-type titanium silicalite, the resulting product and its different uses in the field of catalysis. The inventive method for preparing MEL-type titanium silicalite is characterised in...  
WO/2000/008495A2
The present invention provides a compound selected from the group consisting of (I), (II), and (III), wherein R?1¿ and R?4¿ are the same or different and are each H, C¿1?-C¿3? alkyl, phosphate, or C¿1?-C¿3? alkyl carboxylate; R?2¿...  
WO/2000/002455A1
Hypericin has been shown to specifically inhibit T-type calcium channel activity. $i(Hypericum) extract containing hypericin also inhibits T-type calcium channel activity. Moreover, other chemicals in $i(Hypericum) extract showed a syner...  
WO/1999/061409A1
A compound which consists of a proactive alkylating moiety containing an electron-withdrawing group, a bioreductive moiety containing at least two double bonds, and a linker joining the proactive alkylating moiety and the bioreductive mo...  
WO/1999/052819A1
The invention relates to the anthraquinone cycle for producing hydrogen peroxide using at least two differently substituted 2-alkylanthraquinones and/or their tetrahydro derivatives. According to the inventive method, the working solutio...  
WO/1999/050434A1
The strain of the microorganism Penicillium oxalicum var. Armeniaca CCM 8242 produces an anthraquinonyl carboxylic acid derivative of structural formula (I), which may be used as a colorant, especially as a food colorant or cosmetic colo...  
WO/1999/048491A1
NF-$g(k)B inhibitors containing as the active ingredient benzoquinone derivatives represented by general formula (I), hydroquinone compounds thereof or salts of the same, wherein R¿1?, R¿2? and R¿3? independently represent each H, C¿...  

Matches 151 - 200 out of 2,214